MBX vs. SRRK
MBX (MBX Biosciences, Inc) and SRRK (Scholar Rock Holding Corporation) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past year, MBX returned 155.06% vs 27.96% for SRRK. At a 0.33 correlation, their price movements are largely independent.
Performance
MBX vs. SRRK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MBX achieves a -8.05% return, which is significantly lower than SRRK's -0.57% return.
MBX
- 1D
- -4.23%
- 1M
- -29.21%
- YTD
- -8.05%
- 6M
- -7.61%
- 1Y
- 155.06%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SRRK
- 1D
- -1.13%
- 1M
- -9.49%
- YTD
- -0.57%
- 6M
- -3.20%
- 1Y
- 27.96%
- 3Y*
- 84.27%
- 5Y*
- 8.97%
- 10Y*
- —
MBX vs. SRRK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
MBX MBX Biosciences, Inc | -8.05% | 71.13% | -22.07% |
SRRK Scholar Rock Holding Corporation | -0.57% | 1.92% | 404.32% |
Correlation
The correlation between MBX and SRRK is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Sep 16, 2024 | 0.33 |
Fundamentals
MBX:
$1.35B
SRRK:
$5.57B
MBX:
-$2.30
SRRK:
-$3.49
MBX:
3.09
SRRK:
20.20
MBX:
$0.00
SRRK:
$0.00
MBX:
-$160.00K
SRRK:
-$1.27M
MBX:
-$96.31M
SRRK:
-$394.71M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MBX vs. SRRK — Risk / Return Rank
MBX
SRRK
MBX vs. SRRK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MBX Biosciences, Inc (MBX) and Scholar Rock Holding Corporation (SRRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MBX | SRRK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.74 | ||
| Sortino ratioReturn per unit of downside risk | +1.71 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.14 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 4.15 | 0.81 | +3.34 |
| Martin ratioReturn relative to average drawdown | 7.99 | 1.92 | +6.07 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MBX | SRRK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.17 | 0.43 | +0.74 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.05 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | 0.09 | +0.02 |
Drawdowns
MBX vs. SRRK - Drawdown Comparison
The maximum MBX drawdown since its inception was -77.71%, smaller than the maximum SRRK drawdown of -93.15%. Use the drawdown chart below to compare losses from any high point for MBX and SRRK.
Loading charts...
Drawdown Indicators
| MBX | SRRK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.71% | -93.15% | +15.44% |
Max Drawdown (1Y)Largest decline over 1 year | -37.60% | -34.86% | -2.74% |
Max Drawdown (3Y)Largest decline over 3 years | — | -65.21% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -88.96% | — |
Current DrawdownCurrent decline from peak | -32.78% | -35.61% | +2.83% |
Average DrawdownAverage peak-to-trough decline | -35.04% | -56.44% | +21.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.50% | 14.61% | +4.89% |
Volatility
MBX vs. SRRK - Volatility Comparison
MBX Biosciences, Inc (MBX) has a higher volatility of 23.40% compared to Scholar Rock Holding Corporation (SRRK) at 13.58%. This indicates that MBX's price experiences larger fluctuations and is considered to be riskier than SRRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MBX | SRRK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.40% | 13.58% | +9.82% |
Volatility (6M)Calculated over the trailing 6-month period | 57.78% | 35.86% | +21.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 133.96% | 65.55% | +68.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 118.74% | 180.23% | -61.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 118.74% | 157.72% | -38.98% |
Dividends
MBX vs. SRRK - Dividend Comparison
Neither MBX nor SRRK has paid dividends to shareholders.
Financials
MBX vs. SRRK - Financials Comparison
This section allows you to compare key financial metrics between MBX Biosciences, Inc and Scholar Rock Holding Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MBX and SRRK have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MBX has higher volatility (23.40%) compared to SRRK (13.58%). In terms of maximum drawdown, MBX dropped -77.71% vs SRRK's -93.15%.
MBX currently has the higher Sharpe Ratio (1.17 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MBX and SRRK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer